ArticleNature communications2018
DUSP10 constrains innate IL-33-mediated cytokine production in ST2
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Effects of Early Diet on the Prevalence of Allergic Disease in Children: A Systematic Review and Meta-Analysis.Advances in nutrition (Bethesda, Md.) · 2024Pooled it
- Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential.Nature reviews. Immunology · 2026Review
- Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets.Biomedicines · 2024Review
- A review of CD4Veterinary immunology and immunopathology · 2024Review
- Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis.BMC genomics · 2024Article
- Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis.Diseases (Basel, Switzerland) · 2024Review
- A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses.Nature immunology · 2024Article
- Green carbon dots derived fromFrontiers in immunology · 2024Article
- Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation.Communications biology · 2023Article
- Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis.Nature communications · 2022Article
- Review
- DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma.Frontiers in oncology · 2022Article
- Endothelin-A Receptor Antagonist Alleviates Allergic Airway InflammationFrontiers in immunology · 2022Article
- Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish.Frontiers in immunology · 2022Article
- SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4Frontiers in immunology · 2022Article
- ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice.The Journal of experimental medicine · 2021Article
- Optimal human pathogenic TThe Journal of allergy and clinical immunology · 2021Article
- Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells.Biology · 2021Article
- SCD2-mediated monounsaturated fatty acid metabolism regulates cGAS-STING-dependent type I IFN responses in CD4Communications biology · 2021Article
- Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period.JCI insight · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 3 institutions in 2 countries.
Takeshi YamamotoDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Yusuke EndoDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Atsushi OnoderaDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Kiyoshi HiraharaDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Hikari K AsouDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Takahiro NakajimaDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Toshio KannoDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Yasuo OuchiDepartment of Mucosal Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Satoshi UematsuDepartment of Mucosal Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Hiroshi NishimasuDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, 2-11-16 Yayoi, Bunkyo, Tokyo, 113-0032, Japan.
Osamu NurekiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, 2-11-16 Yayoi, Bunkyo, Tokyo, 113-0032, Japan.ORCID http://orcid.org/0000-0003-1813-7008
Damon J TumesCentre for Cancer Biology, University of South Australia and SA Pathology, cnr North Terrace & Morphett St bridge, GPO Box 2471, Adelaide, SA, 5001, Australia.ORCID http://orcid.org/0000-0001-5709-857X
Naoki ShimojoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan.
Toshinori NakayamaDepartment of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba, 260-8670, Japan. tnakayama@faculty.chiba-u.jp.
Chiba University · JPThe University of Tokyo · JPSouth Australia Pathology · AU
Funding
Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 16H06224Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 18H04665Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 24790461Ministry of Education, Culture, Sports, Science, and Technology (MEXT) #26221305
Abstract
ST2
Indexed as
AnimalsAnimals, Genetically ModifiedChromatin ImmunoprecipitationCytokinesDual-Specificity PhosphatasesEnzyme-Linked Immunosorbent AssayFlow CytometryGATA3 Transcription FactorHumansImmunoblottingInterleukin-33LymphocytesMiceMice, Inbred BALB Cp38 Mitogen-Activated Protein KinasesReal-Time Polymerase Chain ReactionCytokinesDual-Specificity PhosphatasesDusp10 protein, mouseGATA3 Transcription FactorInterleukin-33p38 Mitogen-Activated Protein Kinases
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.